A Phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)

Author： Grünwald Viktor   Desar Ingrid M. E.   Haanen John   Fiedler Walter   Mouritzen Ulrik   Olsen M. W. Brændholt   van Herpen Carla M. L.  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.50, Iss.1, 2011-01, pp. : 121-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

By Bennouna Jaafar   Bompas Emmanuelle   Neidhardt Eve   Rolland Frédéric   Philip Irène   Galéa Céline   Salot Samuel   Saiagh Soraya   Audrain Marie   Rimbert Marie   Lafaye-de Micheaux Sylvie   Tiollier Jérôme   Négrier Sylvie  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1599-1609

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah   Larkin James   Pickering Lisa  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study

By Schuler M.   Bruntsch U.   Spath-Schwalbe E.   Schrezenmeier H.   Peschel C.   Farber L.   Burger K.J.   Leiszner J.   Huber C.   Aulitzky W.E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 754-756

Elsevier

Access to resources Recommend Favorite

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies

By Bruce Justine   Kolesar Jill   Hammers Hans   Stein Mark   Carmichael Lakeesha   Eickhoff Jens   Johnston Susan   Binger Kimberly   Heideman Jennifer   Perlman Scott   Jeraj Robert   Liu Glenn  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 485-493

Springer Publishing Company

Access to resources Recommend Favorite